Đăng xuất
Pregnancy: Animal studies did not reveal any teratogenic or embryofoetotoxic potential of terbinafine hydrochloride.
No cases of malformations in humans have been reported with the use of the drug. There is limited clinical experience in pregnant women. Foetal toxicity studies in animals suggest no adverse effects.
Terbinafine hydrochloride topical solution should not be used during pregnancy unless clearly necessary.
Breast-feeding: Terbinafine hydrochloride is excreted in breast milk. Therefore, mothers should not use the drug during the period of breast-feeding. Infants must not be allowed to come into contact with any treated skin, including the breast.
Fertility: No effect of terbinafine hydrochloride on fertility has been seen in animal studies.
